Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cardinal Health
CAH
|
+$2.2B |
| 2 |
Devon Energy
DVN
|
+$1.93B |
| 3 |
Seagate
STX
|
+$1.77B |
| 4 |
HONA
Honeywell Aerospace
HONA
|
+$1.7B |
| 5 |
IBM
IBM
|
+$1.58B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$2.73B |
| 2 |
Eli Lilly
LLY
|
+$2.48B |
| 3 |
NVIDIA
NVDA
|
+$2.42B |
| 4 |
Honeywell
HON
|
+$2.41B |
| 5 |
Wells Fargo
WFC
|
+$2.12B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.37% |
| 2 | Healthcare | 17.54% |
| 3 | Financials | 13.55% |
| 4 | Industrials | 9.01% |
| 5 | Consumer Discretionary | 7.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
JBIO
1576
Jade Biosciences
JBIO
$1.21B
| $2.01M | ﹤0.01% |
90,396
-38,770
| -30% | -$809K |
|
1577
MDU Resources
MDU
$4.12B
| $2M | ﹤0.01% |
94,397
+29,599
| +46% | +$644K |
|
1578
Rigel Pharmaceuticals
RIGL
$882M
| $1.99M | ﹤0.01% |
50,864
-5,638
| -10% | -$174K |
|
1579
Ironwood Pharmaceuticals
IRWD
$673M
| $1.97M | ﹤0.01% |
468,821
+15,306
| +3% | +$59K |
|
1580
Finward Bancorp
FNWD
$186M
| $1.97M | ﹤0.01% |
53,656
-1,554
| -3% | -$51.9K |
|
1581
First Community Corp
FCCO
$319M
| $1.97M | ﹤0.01% |
60,238
| – | – |
|
1582
Franklin Templeton
BEN
$17.3B
| $1.95M | ﹤0.01% |
58,593
-52,989
| -47% | -$1.59M |
|
1583
Avalo Therapeutics
AVTX
$977M
| $1.95M | ﹤0.01% |
+105,261
| New | +$1.66M |
|
1584
Omeros
OMER
$1.4B
| $1.95M | ﹤0.01% |
204,541
+17,241
| +9% | +$205K |
|
1585
Rackspace Technology
RXT
$826M
| $1.94M | ﹤0.01% |
+296,344
| New | +$1.16M |
|
1586
MeiraGTx Holdings
MGTX
$1.27B
| $1.93M | ﹤0.01% |
142,923
+16,592
| +13% | +$165K |
|
1587
Theravance Biopharma
TBPH
$886M
| $1.93M | ﹤0.01% |
113,481
+3,781
| +3% | +$62.6K |
|
1588
Mueller Industries
MLI
$14.1B
| $1.92M | ﹤0.01% |
+31,198
| New | +$2.05M |
|
|
LBRX
1589
LB Pharmaceuticals
LBRX
$1.54B
| $1.91M | ﹤0.01% |
58,891
+6,251
| +12% | +$184K |
|
1590
Tyra Biosciences
TYRA
$1.31B
| $1.9M | ﹤0.01% |
59,601
-17,568
| -23% | -$581K |
|
1591
CRISPR Therapeutics
CRSP
$5.17B
| $1.9M | ﹤0.01% |
34,828
-41
| -0.1% | -$2.16K |
|
1592
Zegna
ZGN
$4.96B
| $1.89M | ﹤0.01% |
+145,159
| New | +$1.87M |
|
|
ARTV
1593
Artiva Biotherapeutics
ARTV
$528M
| $1.88M | ﹤0.01% |
194,108
| – | – |
|
1594
Cincinnati Financial
CINF
$26B
| $1.88M | ﹤0.01% |
10,146
-896
| -8% | -$149K |
|
1595
Alto Neuroscience
ANRO
$1.34B
| $1.87M | ﹤0.01% |
70,913
+11,114
| +19% | +$257K |
|
1596
Fortive
FTV
$16.9B
| $1.87M | ﹤0.01% |
30,631
+2,104
| +7% | +$126K |
|
1597
Indivior Pharmaceuticals
INDV
$4.1B
| $1.87M | ﹤0.01% |
45,581
-3,548
| -7% | -$129K |
|
1598
Vulcan Materials
VMC
$32.4B
| $1.87M | ﹤0.01% |
6,333
+2,994
| +90% | +$858K |
|
1599
FedEx
FDX
$73.2B
| $1.87M | ﹤0.01% |
5,956
+491
| +9% | +$178K |
|
|
MPLT
1600
MapLight Therapeutics
MPLT
$636M
| $1.86M | ﹤0.01% |
51,917
+5,709
| +12% | +$164K |
|
Similar funds
Wellington Management Group's Q2 2026 Portfolio in Review
As of Q2 2026, Wellington Management Group held 2,097 positions worth $580B, up 8.3% from $535B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Wellington Management Group withdrew a net $23.6B in Q2 2026, closing 176 positions and reducing 867 holdings. Its most notable exit was Coterra Energy, an estimated $1.88B position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Wellington Management Group opened a new position in Honeywell Aerospace worth $1.71B.
- Wellington Management Group's largest Q2 2026 buy was Honeywell Aerospace: 7,716,131 shares worth $1.71B.
- Wellington Management Group added most to Cardinal Health in Q2 2026, an estimated $2.2B increase.
- Wellington Management Group's biggest Q2 2026 reduction was Meta Platforms (Facebook), cutting an estimated $2.73B.
- Wellington Management Group fully exited Coterra Energy in Q2 2026, selling an estimated $1.88B.
- Wellington Management Group's ten largest holdings make up 25% of its $580B portfolio in Q2 2026.
- Wellington Management Group opened 231 new positions and closed 176 in Q2 2026.
- Wellington Management Group's portfolio value rose 8.3% quarter-over-quarter to $580B.
Based on Wellington Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.